Ostrowska Lucyna, Gier Dominika, Zyśk Beata
Department of Dietetics and Clinical Nutrition, Medical University of Bialystok, ul. Mieszka I 4 B, 15-054 Bialystok, Poland.
Faculty of Physiotherapy and Health Sciences, Gdansk College of Health, ul. Pelplińska 7, 80-335 Gdańsk, Poland.
Nutrients. 2021 Mar 5;13(3):862. doi: 10.3390/nu13030862.
Hashimoto's disease is listed among the most common endocrine causes of obesity. As treatment of obesity in women with Hashimoto's disease is frequently unsuccessful, the aim of this study was to evaluate the effectiveness of two different reducing diets and their influence on changes in thyroid parameters in female patients. A six-month observational/interventional study was performed on 100 women aged 18-65 years, previously diagnosed with Hashimoto's disease and obesity and receiving L-thyroxine. The women were randomly assigned to the test group (group A, = 50) following elimination/reducing diets, and the control group (group B, = 50) following reducing diets with the same caloric content (without elimination). Anthropometric and thyroid parameters were evaluated at the beginning, after 3 months and after 6 months of treatment. In both groups a significant decrease in BMI and body fat percentage was achieved, but in test group A the decrease in BMI and body fat percentage was significantly greater than in control group B ( < 0.002 and = 0.026, respectively). Serum TSH (thyroid stimulating hormon) levels decreased significantly more in group A than in group B ( < 0.001). Group A exhibited significantly greater increases in fT4 and fT3 levels than the control group ( < 0.001) as well as significantly greater decreases in the levels anti-TPO (thyroid peroxidase) ( < 0.001) and anti-TG (thyreoglobulin) antibodies ( = 0.048). The application of reducing diets with product elimination was found to be a more beneficial tool for changing anthropometric and thyroid parameters in women suffering from obesity and Hashimoto's disease than classic reducing diets with the same energy values and macronutrient content.
桥本氏病被列为肥胖最常见的内分泌病因之一。由于对患有桥本氏病的女性肥胖症的治疗常常不成功,本研究的目的是评估两种不同的减肥饮食的有效性及其对女性患者甲状腺参数变化的影响。对100名年龄在18 - 65岁、先前被诊断患有桥本氏病和肥胖症且正在接受左甲状腺素治疗的女性进行了为期六个月的观察/干预研究。这些女性被随机分为试验组(A组,n = 50),采用排除/减肥饮食,以及对照组(B组,n = 50),采用热量相同的减肥饮食(无排除)。在治疗开始时、3个月后和6个月后评估人体测量和甲状腺参数。两组的BMI和体脂百分比均显著下降,但试验组A的BMI和体脂百分比下降幅度明显大于对照组B(分别为P < 0.002和P = 0.026)。A组血清促甲状腺激素(TSH)水平的下降幅度明显大于B组(P < 0.001)。A组游离甲状腺素(fT4)和游离三碘甲状腺原氨酸(fT3)水平的升高幅度明显大于对照组(P < 0.001),同时抗甲状腺过氧化物酶(anti - TPO)(P < 0.001)和抗甲状腺球蛋白(anti - TG)抗体水平的下降幅度也明显更大(P = 0.048)。与具有相同能量值和宏量营养素含量的传统减肥饮食相比,采用排除产品的减肥饮食被发现是改变肥胖和桥本氏病女性人体测量和甲状腺参数的更有益工具。